TAMPA, Fla., March 31, 2026 (GLOBE NEWSWIRE)-- Inhibitor Therapeutics, Inc. (OTCQB: INTI) ("Inhibitor" or the "Company"), today provided an update on its ongoing pharmacokinetic (PK) clinical program ...
Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA ...
Formulation Development is a key element in the pharmaceutical development process. There is an increasing trend by companies to outsource not just this service, but an integrated platform of ...
Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial ...
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to develop next-generation therapies ...
Hyderabad, India, July 1, 2015: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage ...
As with addressing or interpreting dreams in therapy—a phenomenon many psychotherapists today sadly dismiss as ...
Oral prolonged-release ketamine formulation (KET01) demonstrates minimal dissociation and cardiovascular effects with early antidepressant efficacy signals in treatment-resistant depressionResults ...
ALBANY, New York, Jan. 19, 2015 /PRNewswire/ -- AMRI (AMRI) today announced it received a 10-year federal contract award from the National Institutes of Health (NIH) for drug development and ...
Channel Therapeutics announced successful pre-clinical results for its non-opioid pain treatment formulations, outperforming bupivacaine in efficacy and duration. Channel Therapeutics Corporation has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results